Gout in ambulatory care settings in the United States

Journal of Rheumatology

Volumn 35, Issue 3, 2008, Pages 498-501

  Krishnan, Eswar ^a   Lienesch, Douglas ^a   Kwoh, C Kent ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Allopurinol; Antiinflammatory; Ethnicity; Gout; Pharmacoepidemiology

Indexed keywords

ALLOPURINOL; COLCHICINE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; GOUT; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNITED STATES;

AFRICAN AMERICANS; AGED; AMBULATORY CARE FACILITIES; ARTHRITIS, GOUTY; ASIAN AMERICANS; DRUG UTILIZATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GOUT SUPPRESSANTS; HEALTH CARE SURVEYS; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; OCEANIC ANCESTRY GROUP; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; UNITED STATES;

EID: 40649127492     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kim KY, Schumacher RH, Hunsche E, Wertheimer AI, Kong SX. A literature review of the epidemiology and treatment of acute gout. Clin Ther 2003;25:1593-617.
2. Choi HK, Curhan G. Gout: epidemiology and lifestyle choices. Curr Opin Rheumatol 2005;17:341-5.
3. Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis 2002;40:37-42.
4. Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004;31:1582-7.
5. Gilchrist VJ, Stange KC, Flocke SA, McCord G, Bourguet CC. A comparison of the National Ambulatory Medical Care Survey (NAMCS) measurement approach with direct observation of outpatient visits. Med Care 2004;42:276-80.
6. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 2005;64:267-72.
7. Mikuls TR, Saag KG. New insights into gout epidemiology. Curr Opin Rheumatol 2006;18:199-203.
8. Yu ES, Cypress BK. Visits to physicians by Asian/Pacific Americans. Med Care 1982;20:809-20.
9. Chou CT, Lai JS. The epidemiology of hyperuricaemia and gout in Taiwan aborigines. Br J Rheumatol 1998;37:258-62.
10. Chang HY, Pan WH, Yeh WT, Tsai KS. Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96). J Rheumatol 2001;28:1640-6.
11. Torralba TP, Bayani-Sioson PS. The Filipino and gout. Semin Arthritis Rheum 1975;4:307-20.
12. Bayani-Sioson PS, Skeith M, Healey LS Jr. On Filipino hyperuricemia. Acta Med Philipp 1966;3:126-7.
13. Zimmet PZ, Whitehouse S, Jackson L, Thoma K. High prevalence of hyperuricaemia and gout in an urbanised Micronesian population. BMJ 1978;1:1237-9.
14. Rose BS. Gout in Maoris. Semin Arthritis Rheum 1975;5:121-45.
15. Tuomilehto J, Zimmet P, Wolf E, Taylor R, Ram P, King H. Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji. Am J Epidemiol 1988;127:321-36.